Skip to main content
. 2019 Mar 15;11(3):1876–1883.

Figure 2.

Figure 2

The relationship between tumor budding levels and survival. Left: The overall survival was longer among the patients with low-grade tumor budding than among those with high-grade tumor budding (P = 0.001). Right: The overall survival was slightly longer among the patients without IL-17-positive tumor budding than among those with IL-17-positive tumor budding (P = 0.008).